Related Experiment Video
Updated: Mar 7, 2026

Oxygen-Glucose Deprivation and Reoxygenation as an In Vitro Ischemia-Reperfusion Injury Model for Studying Blood-Brain Barrier Dysfunction
Published on: May 7, 2015
TNFα alters occludin and cerebral endothelial permeability: Role of p38MAPK
Yawen Ni1, Tao Teng2, Runting Li3
1Department of Bioengineering, University of Missouri, Columbia, Missouri, United States of America.
Abstract:
Occludin is a key tight junction (TJ) protein in cerebral endothelial cells (CECs) playing an important role in modulating blood-brain barrier (BBB) functions. This protein (65kDa) has been shown to engage in many signaling pathways and phosphorylation by both tyrosine and threonine kinases. Despite yet unknown mechanisms, pro-inflammatory cytokines and endotoxin (lipopolysaccharides, LPS) may alter TJ proteins in CECs and BBB functions. Here we demonstrate the responses of occludin in an immortalized human cerebral endothelial cell line (hCMEC/D3) to stimulation by TNFα (10 ng/mL), IL-1β (10 ng/mL) and LPS (100 ng/mL). Exposing cells to TNFα resulted in a rapid and transient upward band-shift of occludin, suggesting of an increase in phosphorylation. Exposure to IL-1β produced significantly smaller effects and LPS produced almost no effects on occludin band-shift. TNFα also caused transient stimulation of p38MAPK and ERK1/2 in hCMEC/D3 cells, and the occludin band-shift induced by TNFα was suppressed by SB202190, an inhibitor for p38MAPK, and partly by U0126, the MEK1/2-ERK1/2 inhibitor. Cells treated with TNFα and IL-1β but not LPS for 24 h resulted in a significant (p < 0.001) decrease in the expression of occludin, and the decrease could be partially blocked by SB202190, the inhibitor for p38MAPK. Treatment with TNFα also altered cell morphology and enhanced permeability of the CEC layer as measured by the FITC-dextran assay and the trans-endothelial electrical resistances (TEER). However, treatment with SB202190 alone could not effectively reverse the TNFα -induced morphology changes or the enhanced permeability changes. These results suggest that despite effects of TNFα on p38MAPK-mediated occludin phosphorylation and expression, these changes are not sufficient to avert the TNFα-induced alterations on cell morphology and permeability.
Insights
Tumor necrosis factor-alpha (TNFα) rapidly increases occludin phosphorylation in brain endothelial cells, but prolonged exposure decreases occludin expression and increases blood-brain barrier permeability. p38MAPK inhibition partially mitigates these effects.
Area of Science:
- Neuroscience
- Cell Biology
- Immunology
Background:
- Occludin is a critical tight junction protein in cerebral endothelial cells (CECs) that regulates blood-brain barrier (BBB) function.
- Pro-inflammatory cytokines and endotoxins can disrupt TJ proteins and BBB integrity, but the precise mechanisms remain unclear.
- Understanding how specific cytokines impact occludin is vital for addressing BBB dysfunction.
Purpose of the Study:
- To investigate the effects of TNFα, IL-1β, and LPS on occludin phosphorylation and expression in human cerebral endothelial cells (hCMEC/D3).
- To explore the involvement of p38MAPK and ERK1/2 signaling pathways in TNFα-induced occludin modulation.
- To assess the impact of TNFα on CEC morphology and BBB permeability.
Main Methods:
- Human cerebral endothelial cells (hCMEC/D3) were stimulated with TNFα, IL-1β, and LPS.
- Occludin phosphorylation was assessed via Western blot (band-shift analysis).
- p38MAPK and ERK1/2 activation were measured, and specific inhibitors (SB202190, U0126) were used to probe signaling pathways. Cell morphology and permeability (FITC-dextran assay, TEER) were also evaluated.
Main Results:
- TNFα induced rapid, transient occludin phosphorylation and transient p38MAPK/ERK1/2 activation, which were partially inhibited by SB202190 and U0126, respectively.
- Prolonged TNFα and IL-1β treatment significantly decreased occludin expression, partially blocked by SB202190.
- TNFα altered cell morphology and increased CEC layer permeability, but SB202190 did not fully reverse these changes.
Conclusions:
- TNFα significantly impacts occludin phosphorylation and expression in CECs, involving p38MAPK and ERK1/2 pathways.
- While p38MAPK inhibition can partially mitigate TNFα-induced changes in occludin expression, it is insufficient to fully restore BBB integrity.
- These findings highlight complex TNFα-mediated effects on the BBB, suggesting that occludin phosphorylation and expression changes alone do not entirely explain permeability alterations.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

